drugset / Trial / NCT00575913
Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality Study
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To assess, under daily practice conditions, the safety profile and the efficacy of a new formulation of alfuzosin administered once daily (Xatral XL) in patients with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH).
Timeline
- Start
- 2003-09
- Primary completion
- —
- Completion
- 2005-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alfuzosin | Small molecule | 10 mg | — |